MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA

Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x Solez, 2008, Banff 07 classification of renal allograft pathology: Updates and future directions. Am, J Transplant, 8, 753 Schold, 2010, The elephant in the room: Failings of current clinical endpoints in kidney transplantation, Am J Transplant, 10, 1163, 10.1111/j.1600-6143.2010.03104.x Poggio, 2007, Evaluation of renal function in transplantation, Transplantation, 84, 131, 10.1097/01.tp.0000269108.59275.dc Manotham, 2002, Accurately simple estimation of glomerular filtration rate in kidney transplant patients, Transplant Proc, 34, 1148, 10.1016/S0041-1345(02)02788-4 Mariat, 2004, Assessing renal graft function in clinical trials: Can tests predicting glomerular filtration rate substitute for a reference method?, Kidney Int., 65, 289, 10.1111/j.1523-1755.2004.00350.x Gaspari, 2004, Performance of different prediction equations for estimating renal function in kidney transplantation, Am J Transplant, 4, 1826, 10.1111/j.1600-6143.2004.00579.x Bosma, 2005, Predictive performance of renal function equations in renal transplant recipients: An analysis of patient factors in bias, Am J Transplant, 5, 2193, 10.1111/j.1600-6143.2005.00982.x Pascual, 1999, The clinical usefulness of the renal allograft biopsy in the cyclosporine era: A prospective study, Transplantation, 67, 737, 10.1097/00007890-199903150-00016 Furness, 2007, Predicting allograft survival: Abundant data, but insufficient knowledge?, Transplantation, 83, 681, 10.1097/01.tp.0000262005.84789.de Rush, 2009, Can protocol biopsy better inform our choices in renal transplantation?, Transplant Proc, 41, S6, 10.1016/j.transproceed.2009.06.092 Gillespie, 2008, Biomarkers in renal transplantation, Biomark Med, 2, 603, 10.2217/17520363.2.6.603 Fabian, 2010, Regulation of mRNA translation and stability by microRNAs, Annu Rev Biochem, 79, 351, 10.1146/annurev-biochem-060308-103103 Kasinath, 2009, Regulation of mRNA translation in renal physiology and disease, Am J Physiol Renal Physiol, 297, F1153, 10.1152/ajprenal.90748.2008 Eulalio, 2008, Getting to the root of miRNA-mediated gene silencing, Cell, 132, 9, 10.1016/j.cell.2007.12.024 Vasudevan, 2007, Switching from repression to activation: MicroRNAs can up-regulate translation, Science, 318, 1931, 10.1126/science.1149460 Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 Reid, 2010, Circulating microRNAs: Association with disease and potential use as biomarkers, Crit Rev Oncol Hematol Li, 2010, Review: The role of microRNAs in kidney disease, Nephrology (Carlton), 15, 599, 10.1111/j.1440-1797.2010.01363.x Anglicheau, 2009, MicroRNA expression profiles predictive of human renal allograft status, Proc Natl Acad Sci U S A, 106, 5330, 10.1073/pnas.0813121106 Sui, 2008, Microarray analysis of MicroRNA expression in acute rejection after renal transplantation, Transpl Immunol, 19, 81, 10.1016/j.trim.2008.01.007 Halloran, 2004, Assessing long-term nephron loss: Is it time to kick the CAN grading system?, Am J Transplant, 4, 1729, 10.1111/j.1600-6143.2004.00662.x Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Scian, 2011, Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: Diagnosis versus prediction, Transplantation, 91, 657, 10.1097/TP.0b013e3182094a5a Cunningham, 2009, Evaluation of a new high-dimensional miRNA profiling platform, BMC Med Genomics, 2, 57, 10.1186/1755-8794-2-57 Chen, 2009, ToppGene Suite for gene list enrichment analysis and candidate gene prioritization, Nucleic Acids Res, 37, W305, 10.1093/nar/gkp427 Xiao, 2009, miRecords: An integrated resource for microRNA-target interactions, Nucleic Acids Res, 37, D105, 10.1093/nar/gkn851 Cherukuri, 2010, The clinical significance of early proteinuria after renal transplantation, Transplantation, 89, 200, 10.1097/TP.0b013e3181c352c5 Scherer, 2009, Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months, Nephrol Dial Transplant, 24, 2567, 10.1093/ndt/gfp183 Mas, 2010, Molecular pathways involved in loss of graft function in kidney transplant recipients, Expert Rev Mol Diagn, 10, 269, 10.1586/erm.10.6 Nankivell, 2006, Chronic allograft nephropathy: Current concepts and future directions, Transplantation, 81, 643, 10.1097/01.tp.0000190423.82154.01 Jevnikar, 2008, Late kidney allograft loss: What we know about it, and what we can do about it, Clin J Am Soc Nephrol, 3, S56, 10.2215/CJN.03040707 Li, 2009, The pathogenesis and treatment of chronic allograft nephropathy, Nat Rev Nephrol, 5, 513, 10.1038/nrneph.2009.113 Fletcher, 2009, Chronic allograft nephropathy, Pediatr Nephrol, 24, 1465, 10.1007/s00467-008-0869-z Mueller, 2008, The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function, Am J Transplant, 8, 78, 10.1111/j.1600-6143.2007.02032.x Hauser, 2004, Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function, Lab Invest, 84, 353, 10.1038/labinvest.3700037 Cosio, 2005, Kidney allograft fibrosis and atrophy early after living donor transplantation, Am J Transplant, 5, 1130, 10.1111/j.1600-6143.2005.00811.x Nankivell, 2004, Natural history, risk factors, and impact of subclinical rejection in kidney transplantation, Transplantation, 78, 242, 10.1097/01.TP.0000128167.60172.CC Nankivell, 2004, Delta analysis of posttransplantation tubulointerstitial damage, Transplantation., 78, 434, 10.1097/01.TP.0000128613.74683.D9 Moreso, 2006, Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss, Am J Transplant, 6, 747, 10.1111/j.1600-6143.2005.01230.x Huang, 2009, miR-142–3p restricts cAMP production in CD4+CD25– T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA, EMBO Rep, 10, 180, 10.1038/embor.2008.224 Aquino-Dias, 2008, Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function, Kidney Int, 73, 877, 10.1038/sj.ki.5002795 Afaneh, 2010, Urinary Cell Levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and Acute Rejection of Human Renal Allografts, Transplantation, 90, 1381, 10.1097/TP.0b013e3181ffbadd Muthukumar, 2005, Messenger RNA for FOXP3 in the urine of renal-allograft recipients, N Engl J Med, 353, 2342, 10.1056/NEJMoa051907 Bunnag, 2008, FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes, Am J Transplant, 8, 1423, 10.1111/j.1600-6143.2008.02268.x Merkerova, 2008, Differential expression of microRNAs in hematopoietic cell lineages, Eur J Haematol, 81, 304, 10.1111/j.1600-0609.2008.01111.x Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 Ambs, 2008, Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Res, 68, 6162, 10.1158/0008-5472.CAN-08-0144 Pichiorri, 2008, MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis, Proc Natl Acad Sci U S A, 105, 12885, 10.1073/pnas.0806202105 Guled, 2009, CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis, Genes Chromosomes Cancer, 48, 615, 10.1002/gcc.20669 Petillo, 2009, MicroRNA profiling of human kidney cancer subtypes, Int J Oncol, 35, 109, 10.3892/ijo_00000318 Dacic, 2010, miRNA expression profiling of lung adenocarcinomas: Correlation with mutational status, Mod Pathol, 23, 1577, 10.1038/modpathol.2010.152 Mascaux, 2009, Evolution of microRNA expression during human bronchial squamous carcinogenesis, Eur Respir J, 33, 352, 10.1183/09031936.00084108 Cheng, 2005, Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis, Nucleic Acids Res, 33, 1290, 10.1093/nar/gki200 Linsley, 2007, Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression, Mol Cell Biol, 27, 2240, 10.1128/MCB.02005-06 Takahashi, 2009, MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines, PLoS One, 4, e6677, 10.1371/journal.pone.0006677 Lee, 2009, Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer, Pancreatology, 9, 293, 10.1159/000186051 Shi, 2008, Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis, J Am Soc Nephrol, 19, 2159, 10.1681/ASN.2008030312 Ho, 2008, Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury, J Am Soc Nephrol, 19, 2069, 10.1681/ASN.2008020162 Harvey, 2008, Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease, J Am Soc Nephrol, 19, 2150, 10.1681/ASN.2008020233 Nagalakshmi, 2011, Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney, Kidney Int, 79, 317, 10.1038/ki.2010.385